Literature DB >> 26668538

Is sentinel lymph node biopsy enough for axillary macrometastasis?

Merdan Fayda1, Makbule Tambaş1, Hasan Karanlık2.   

Abstract

Year:  2015        PMID： 26668538      PMCID： PMC4674053          DOI： 10.5152/UCD.2015.3076

Source DB:  PubMed          Journal:  Ulus Cerrahi Derg        ISSN： 1300-0705


× No keyword cloud information.
  8 in total

1.  Axillary versus sentinel-lymph-node dissection for micrometastatic breast cancer.

Authors:  Merdan Fayda; Hasan Karanlik
Journal:  Lancet Oncol       Date:  2013-06       Impact factor: 41.316

2.  St. Gallen 2013: brief preliminary summary of the consensus discussion.

Authors:  Nadia Harbeck; Christoph Thomssen; Michael Gnant
Journal:  Breast Care (Basel)       Date:  2013-05       Impact factor: 2.860

3.  Axillary vs sentinel lymph node dissection for invasive breast cancer.

Authors:  Seenu Vuthaluru; Anurag Srivastava
Journal:  JAMA       Date:  2011-06-08       Impact factor: 56.272

4.  Radiation field design in the ACOSOG Z0011 (Alliance) Trial.

Authors:  Reshma Jagsi; Manjeet Chadha; Janaki Moni; Karla Ballman; Fran Laurie; Thomas A Buchholz; Armando Giuliano; Bruce G Haffty
Journal:  J Clin Oncol       Date:  2014-08-18       Impact factor: 44.544

5.  Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.

Authors:  Mila Donker; Geertjan van Tienhoven; Marieke E Straver; Philip Meijnen; Cornelis J H van de Velde; Robert E Mansel; Luigi Cataliotti; A Helen Westenberg; Jean H G Klinkenbijl; Lorenzo Orzalesi; Willem H Bouma; Huub C J van der Mijle; Grard A P Nieuwenhuijzen; Sanne C Veltkamp; Leen Slaets; Nicole J Duez; Peter W de Graaf; Thijs van Dalen; Andreas Marinelli; Herman Rijna; Marko Snoj; Nigel J Bundred; Jos W S Merkus; Yazid Belkacemi; Patrick Petignat; Dominic A X Schinagl; Corneel Coens; Carlo G M Messina; Jan Bogaerts; Emiel J T Rutgers
Journal:  Lancet Oncol       Date:  2014-10-15       Impact factor: 41.316

6.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.

Authors:  Armando E Giuliano; Kelly K Hunt; Karla V Ballman; Peter D Beitsch; Pat W Whitworth; Peter W Blumencranz; A Marilyn Leitch; Sukamal Saha; Linda M McCall; Monica Morrow
Journal:  JAMA       Date:  2011-02-09       Impact factor: 56.272

7.  The extent of extracapsular extension may influence the need for axillary lymph node dissection in patients with T1-T2 breast cancer.

Authors:  Jessica Gooch; Tari A King; Anne Eaton; Lynn Dengel; Michelle Stempel; Adriana D Corben; Monica Morrow
Journal:  Ann Surg Oncol       Date:  2014-04-29       Impact factor: 5.344

8.  Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.

Authors:  Viviana Galimberti; Bernard F Cole; Stefano Zurrida; Giuseppe Viale; Alberto Luini; Paolo Veronesi; Paola Baratella; Camelia Chifu; Manuela Sargenti; Mattia Intra; Oreste Gentilini; Mauro G Mastropasqua; Giovanni Mazzarol; Samuele Massarut; Jean-Rémi Garbay; Janez Zgajnar; Hanne Galatius; Angelo Recalcati; David Littlejohn; Monika Bamert; Marco Colleoni; Karen N Price; Meredith M Regan; Aron Goldhirsch; Alan S Coates; Richard D Gelber; Umberto Veronesi
Journal:  Lancet Oncol       Date:  2013-03-11       Impact factor: 41.316
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.